Patents by Inventor James Malter

James Malter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130149721
    Abstract: Compositions and uses of mGluR5 antagonists for the treatment and inhibition of amyloid precursor protein (APP), A? protein, and APP proteolytic products in Alzheimer's disease, Fragile X Syndrome, autism, and Down's Syndrome are provided. The invention provides methods for diagnosing Fragile X Syndrome via the assessment of A?1-42 levels in blood plasma.
    Type: Application
    Filed: May 22, 2012
    Publication date: June 13, 2013
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: James Malter, Cara Westmark
  • Publication number: 20090239888
    Abstract: Compositions and uses of mGluR5 antagonists for the treatment and inhibition of amyloid precursor protein (APP), A? protein, and APP proteolytic products in Alzheimer's disease, Fragile X Syndrome, autism, and Down's Syndrome are provided. The invention provides methods for diagnosing Fragile X Syndrome via the assessment of A?1-42 levels in blood plasma.
    Type: Application
    Filed: February 12, 2009
    Publication date: September 24, 2009
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: James Malter, Cara Westmark
  • Publication number: 20060264359
    Abstract: The invention provides pharmaceutical compositions and methods of treating immunological disorders. The invention also provides pharmaceutical compositions and methods of inducing eosinophil apoptosis, and methods for treating eosinophil-associated disorders comprising inducing eosinophil apoptosis in an individual in need thereof.
    Type: Application
    Filed: May 12, 2006
    Publication date: November 23, 2006
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: James Malter, Stephane Esnault, Zhong-Jian Shen